Margarita Pileckytė

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

A. J. Tyndall, Bettina Bannert, Paolo Airó et al. · Annals of the Rheumatic Diseases · 2010 · 1.4K citations · Full text

Public Health, Biostatistics, Cardiology +14

Hypoxia‐induced increase in the production of extracellular matrix proteins in systemic sclerosis

Jörg H. W. Distler, Astrid Jüngel, Margarita Pileckytė et al. · Arthritis & Rheumatism · 2007 · 197 citations

Medicine, Dermatology, Pathobiology +17

Dual inhibition of c‐abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis

Alfiya Akhmetshina, Clara Dees, Margarita Pileckytė et al. · The FASEB Journal · 2008 · 187 citations

Medicine, Pharmacology, Pharmacotherapy +17

Phase <scp>III</scp> Randomized Study of <scp>SB</scp>5, an Adalimumab Biosimilar, Versus Reference Adalimumab in Patients With Moderate‐to‐Severe Rheumatoid Arthritis

Michael E. Weinblatt, Asta Baranauskaitė, Jaroslaw Niebrzydowski et al. · Arthritis & Rheumatology · 2017 · 133 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

Src kinases in systemic sclerosis: Central roles in fibroblast activation and in skin fibrosis

Catherine Skhirtladze, Oliver Distler, Clara Dees et al. · Arthritis & Rheumatism · 2008 · 122 citations

Life Sciences, Cell Biology, Pathobiology +17